Stay updated on SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial

Sign up to get notified when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.3%
    Check dated 2025-05-08T13:38:34.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.4%
    Check dated 2025-05-01T06:10:49.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-04-23T23:42:00.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant content removal regarding biliary tract cancer, including detailed statistics and clinical information, while a new clinical trial for NK cell therapy in combination with pembrolizumab has been added.
    Difference
    44%
    Check dated 2025-04-16T20:24:20.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.4%
    Check dated 2025-04-09T13:27:04.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Difference
    0.3%
    Check dated 2025-04-02T00:06:08.000Z thumbnail image

Stay in the know with updates to SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SMT-NK with Pembrolizumab in Biliary Tract Cancer Clinical Trial page.